Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 198.13

-0.3%

Feb 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: celeryroot.com who wrote (7851)	9/27/1997 10:10:00 PM
From: Andrew H	of 32384

Here is the section of the release which gives the 30K figure. Unfortunately, it gives no indication whether it is US or total. However, since it mentions FDA approval, one might speculate that the figure refers to the American market. >>According to terms of the deal, Ligand receives exclusive rights to oral and topical Panretin, the compound that is closest to commercialization. Ligand plans to apply for Food and Drug Administration approval of topical Panretin for Kaposi's sarcoma by early next year. A spokeswoman said that Ligand expects that about 30,000 AIDS patients would qualify for the Panretin topical treatment, if it is approved. Ligand also has Panretin oral capsules in Phase III trials for leukemia. Ligand also gets rights to two more of the venture's most advanced compounds--ALRT 268 and ALRT 324, being developed for non-insulin dependent diabetics. <<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next